PMID: 8473426Feb 1, 1993Paper

A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization

Human Reproduction
M J MacDougallH S Jacobs

Abstract

The outcome of in-vitro fertilization and embryo transfer (IVF-ET) was compared in 76 patients with polycystic ovaries (PCO) diagnosed on pre-treatment ultrasound scan, and 76 control patients who had normal ovaries and were matched for age, cause of infertility and stimulation regimen. Despite receiving significantly less human menopausal gonadotrophin (HMG), patients with PCO, as compared with controls, had significantly higher serum oestradiol levels on the day of human chorionic gonadotrophin administration (5940 +/- 255 versus 4370 +/- 240 pmol/l, P < 0.001), developed more follicles (14.9 +/- 0.7 versus 9.8 +/- 0.6, P < 0.001) and produced more oocytes (9.3 +/- 0.6 versus 6.8 +/- 0.5, P = 0.003). However, fertilization rates were reduced in the PCO patients (52.8 +/- 3.4% versus 66.1 +/- 3.4%, P = 0.007). There was no significant difference in cleavage rates. The pregnancy rate/embryo transfer was 25.4% in the PCO group and 23.0% in the group with normal ovaries. There were three high order multiple pregnancies in the PCO group compared with none in the group with normal ovaries. Of the PCO patients, 10.5% developed moderate/severe ovarian hyperstimulation syndrome (OHSS) compared with none of the controls (P = 0.006). Pa...Continue Reading

Citations

Jan 1, 1997·Journal of Assisted Reproduction and Genetics·S Franks
Feb 19, 1998·The Journal of Clinical Endocrinology and Metabolism·M Van Der MeerJ Schoemaker
Feb 28, 2006·Human Reproduction·Thomas TangAdam H Balen
Dec 12, 2007·Journal of Assisted Reproduction and Genetics·David BaradNorbert Gleicher
Dec 17, 2009·The Mount Sinai Journal of Medicine, New York·Gerardo VelaAlan B Copperman
Jun 8, 2011·Journal of Assisted Reproduction and Genetics·Bulent GulekliSeda S Dogan
Feb 9, 2016·Obstetrics and Gynecology·Sarah DruckenmillerNicole Noyes
Jan 1, 1997·Journal of Assisted Reproduction and Genetics·A Shulman, J Dor
Feb 15, 2002·Human Fertility : Journal of the British Fertility Society·Jamal Zaidi
Jun 19, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Eda Vrtacnik-BokalIvan Verdenik
Oct 11, 2005·Critical Care Medicine·Marie M BudevTommaso Falcone
Feb 17, 2007·Clinical Obstetrics and Gynecology·Kathleen Lin, Christos Coutifaris
Jun 15, 2007·Human Fertility : Journal of the British Fertility Society·Raj MathurJulian Jenkins
Jun 11, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Pornanong AramwitKarnphat Jammeechai
Jan 7, 2015·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Jie-Xue PanHe-Feng Huang
May 1, 1997·Journal of Assisted Reproduction and Genetics·F CanoA Pellicer
Sep 6, 2007·Human Fertility : Journal of the British Fertility Society·K JayaprakasanA P Murdoch
Jun 16, 2005·Acta Obstetricia Et Gynecologica Scandinavica·Ian TummonDonna Session
Sep 22, 2010·Expert Opinion on Pharmacotherapy·Andrea Riccardo GenazzaniPaolo Giovanni Artini
Jan 11, 2008·Biology of Reproduction·Andrea DiLuigiLisa M Mehlmann
Oct 9, 2013·The Cochrane Database of Systematic Reviews·Charalampos S SiristatidisSiladitya Bhattacharya
Nov 7, 2014·Journal of Assisted Reproduction and Genetics·Fernanda Bertuccez CordeiroEdson Guimarães Lo Turco
Aug 1, 1997·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·D GrochowskiM Szamatowicz
Jul 1, 1995·British Journal of Obstetrics and Gynaecology·M Hull
Feb 15, 2002·Human Fertility : Journal of the British Fertility Society·Rina Agrawal
Sep 5, 2002·Molecular Reproduction and Development·Juan J TarínAntonio Cano
Jul 17, 2004·Human Reproduction·D Nikolaou, C Gilling-Smith
May 7, 2004·Current Opinion in Obstetrics & Gynecology·Ri-Cheng ChianSeang-Lin Tan
Jul 10, 2018·Endocrine Reviews·Ali AbbaraWaljit S Dhillo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.